Clinical trials are fundamental to cancer research and are conducted in multiple phases to evaluate the safety and efficacy of new treatments. Phase I trials assess safety and dosage, Phase II trials evaluate efficacy and side effects, and Phase III trials compare the new treatment with the current standard of care. Regulatory bodies closely monitor these trials to ensure compliance with ethical and scientific standards.
